U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07709780) titled 'Apixaban Versus Warfarin for Left Ventricular Thrombus' on July 09.
Brief Summary: Left ventricular thrombus is a blood clot that forms in the left ventricle and is associated with risk of systemic embolism and ischemic stroke. Warfarin has historically been used for anticoagulation in this condition, but it requires frequent international normalized ratio monitoring and is affected by dietary and drug interactions. Apixaban is a direct oral factor Xa inhibitor with fixed dosing and no routine anticoagulation monitoring requirement, and it is increasingly used in clinical practice for left ventricular thrombus, although definitive r...